International Biotechnology Trust PLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

International Biotechnology Trust PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$83.14 - $145.99 $10.9 Million - $19.1 Million	-130,900 Closed	0 $0
Q1 2022 May 20, 2022	SELL	$110.08 - $142.92 $990,720 - $1.29 Million	-9,000 Reduced 6.43%	130,900 $15.5 Million
Q4 2021 Feb 15, 2022	SELL	$99.73 - $148.48 $3.64 Million - $5.42 Million	-36,500 Reduced 20.69%	139,900 $19.3 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $1.54 Million - $2.2 Million	-24,000 Reduced 11.98%	176,400 $12.1 Million
Q4 2020 Feb 19, 2021	BUY	$65.07 - $98.24 $4.1 Million - $6.19 Million	63,000 Added 45.85%	200,400 $17.2 Million
Q3 2020 Dec 01, 2020	BUY	$59.04 - $77.95 $5.46 Million - $7.2 Million	92,400 Added 205.33%	137,400 $8.93 Million
Q2 2020 Jul 14, 2020	BUY	$29.01 - $74.23 $1.31 Million - $3.34 Million	45,000 New	45,000 $3.12 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $1.9 Million - $2.52 Million	-50,949 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $833,560 - $1.4 Million	20,949 Added 69.83%	50,949 $2.23 Million
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $1.04 Million - $1.6 Million	30,000 New	30,000 $1.54 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.